Compare Abeona Therapeutics Inc (ABEO) vs MobilEye Global Inc (MBLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs MobilEye Global Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while MobilEye Global Inc trades at $8.9 (market cap $7.54B). The key difference: MobilEye Global Inc is far larger — about 17.9× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, MobilEye Global Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | MBLY | |
|---|---|---|
Market Cap | $421.19M | $7.54B |
Sector | Health | Technology |
52-Week High | $7.45 | $15.54 |
52-Week Low | $4.17 | $6.56 |
Enterprise Value | $276.10M | $6.10B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About MobilEye Global Inc
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →
